Naren Ramakrishna

The University of Texas MD Anderson Cancer Center, Orlando Health

Papers

Total Citations

147

H-Index

About

Naren Ramakrishna is a leading figure in the cost-effectiveness analysis of prostate cancer treatments, most renowned for his seminal 2012 study on primary treatments for clinically localised prostate cancer. This landmark work, which has garnered over 127 citations, provides the most comprehensive lifetime cost-utility analysis available, directly comparing the comparative effectiveness and economic impact of multiple treatment alternatives. Beyond health economics, Ramakrishna has made significant contributions to the technological advancement of radiosurgery, authoring a key review on the development and proliferation of both Gamma Knife and linear accelerator systems. His research also extends to the precision of proton therapy, where he has investigated the effectiveness of base-of-skull immobilization systems to enhance daily repositioning accuracy for intracranial tumors. Through his work on 6 degrees of freedom robotic couches and intra-fractional uncertainty analysis, Ramakrishna continues to push the boundaries of treatment precision, solidifying his impact on both the clinical and technological fronts of radiation oncology.